Zhong Ji Longevity Science revises debt repayment terms for 25% Asian Integrated Cell Laboratory stake purchasePUBT·Oct 27, 2026 at 01:04 PM029420.00%007670.00%
Zhong Ji Longevity Science Extends Cell Lab Deal Timeline and Delays CircularTip Ranks·Sep 14, 2026 at 01:39 PM007670.00%
Zhong Ji Longevity Science HY26 loss narrows 50% to HK$6.37 million; revenue rises 49% to HK$71.53 millionPUBT·Aug 27, 2026 at 02:57 PM007670.00%
Zhong Ji Longevity Science Group Delays Circular on Cell Lab Stake AcquisitionTip Ranks·Aug 21, 2026 at 11:41 AM007670.00%
Zhong Ji Longevity Science Group amends convertible notes maturity terms under acquisition dealPUBT·Aug 21, 2026 at 10:07 AM007670.00%
Zhong Ji Longevity Science Group schedules board meeting to review interim results, consider dividendPUBT·Aug 17, 2026 at 11:54 AM007670.00%
Zhong Ji Longevity Science Group to Launch RMB1 Billion Health-Focused M&A FundTip Ranks·Jul 7, 2026 at 02:07 PM007670.00%
Zhong Ji Longevity Science issues supplemental 2025 annual report disclosure on investment strategy and convertible notes disputePUBT·Jul 6, 2026 at 08:32 AM007670.00%
Zhong Ji Longevity Science Group Clarifies Investment Strategy and Oversight in 2025 ReportTip Ranks·Jul 2, 2026 at 02:09 PM007670.00%
Zhong Ji Longevity issues supplemental disclosure on 2025 annual report investment strategyPUBT·Jul 2, 2026 at 01:39 PM007670.00%
Zhong Ji Longevity Science Delays Circular on Asian Cell Lab AcquisitionTip Ranks·Jun 10, 2026 at 03:10 PM007670.00%
Zhong Ji Longevity Science Group Further Delays Circular on Cell Lab Stake AcquisitionTip Ranks·Apr 8, 2026 at 02:12 PM513120-2.54%007670.00%
Zhong Ji Longevity Advances IP Transfer to Clear Key Condition for Stem Cell Unit AcquisitionTip Ranks·Apr 2, 2026 at 03:50 PM007670.00%513120-2.54%
Zhong Ji Longevity Science Sets Out Board and Committee StructureTip Ranks·Feb 10, 2026 at 01:07 PM007670.00%